Matthew Smith
MD
Director, Genitourinary Oncology Program
👥Biography 个人简介
Matthew Smith at Massachusetts General Hospital has made major contributions to prostate cancer treatment, including the development of lutetium-177-PSMA-617 radioligand therapy. His involvement in the VISION trial demonstrating lutetium-PSMA's survival benefit in mCRPC helped establish the first approved radiopharmaceutical for this disease. His research also spans bone-targeted therapy and novel AR-pathway inhibitors.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Matthew Smith 的研究动态
Follow Matthew Smith's research updates
留下邮箱，当我们发布与 Matthew Smith（Massachusetts General Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment